Hyperthermic intraperitoneal chemotherapy (HIPEC) is a surgical intervention that addresses advanced abdominal cancers such as appendiceal, colorectal, ovarian, and stomach cancers that have spread to the peritoneal lining. The procedure allows high doses of heated chemotherapy to be delivered directly into the abdomen, significantly improving treatment outcomes and reducing side effects in comparison to systemic chemotherapy. This innovation in cancer treatment greatly enhances the quality of life for patients.

Hyperthermic intraperitoneal chemotherapy, commonly known as HIPEC, is a specialised surgical procedure. This method is employed to manage advanced abdominal cancers, including those of the appendix, colon, stomach, ovaries and peritoneum. HIPEC is performed by directing high doses of heated chemotherapy directly to the cancer cells in the abdominal cavity. It not only improves treatment outcomes but also diminishes systemic side effects.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is designed to manage advanced cancer that has spread to the abdominal cavity. The treatment involves pumping heated chemotherapy drugs into the abdominal cavity to target malignant cells. The main purpose of this procedure is to eliminate remaining cancer cells after removing visible tumours and diseased tissue.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a specialised surgical technique employed predominantly for the treatment of peritoneal metastases from various forms of cancer such as ovarian, colorectal, stomach and appendix cancers. The procedure comprises two critical stages; cytoreductive surgery, which involves the removal of visible tumours from the peritoneal cavity, and HIPEC itself, wherein a heated, sterile solution containing a chemotherapeutic agent is circulated through the peritoneal cavity.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is an advanced surgical procedure for patients suffering from cancer of the abdominal (peritoneal) cavity. Pioneered by top HIPEC surgeons, this technique involves removing visible tumours from the abdominal cavity and then circulating a heated, sterile solution with a chemotherapeutic agent through the same space. By directly targeting cancer cells and minimising systemic side effects, HIPEC has gained considerable recognition for its enhanced efficacy and improved patient quality of life.